Home > Journals > Indian Journal of Anesthesia and Analgesia

Indian Journal of Anesthesia and Analgesia

Submit your article Read this Journals View all journals
Full Text (PDF)
Original Article

Comparison of Equipotent Doses of Cisatracurium and Rocuronium at Bhuj, Kutch

Hemali Chande, Assistant Professor, Department of Anaesthesia, Gujarat Adani Institute of Medical Science, Bhuj, Gujarat 370001, India. , Hemali Chande1 , Hitesh Patel2

Author Information

Licence:



Indian Journal of Anesthesia and Analgesia 4(3):p 801-804, July - September 2017. | DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.4317.41

How Cite This Article:

Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background and Aim: For several decades, suxamethonium was the gold standard relaxant for rapid sequence intubation. However, the unintended side-effects such as muscle fasciculation, hyperkalemia, rise in intracranial and intraocular pressures led to the search of newer relaxants. In this study we compared the most recent rocuronium and cisatracurium at a dose as regard the onset of action, intubating conditions, efficacy, and safety during general anesthesia for adult gynecological ambulatory surgery. Materials & Methods: Total of 90 patients were randomly selected and included in the present study. The age range for the patient was found to be 25 to 65 years. All the included patients were randomly divided into two groups, 45 patients in each group. In the first group Rocuronium 0.6 mg/kg was administered and in other group 0.1 mg/kg was administered. Results: The time to achieve maximum blockade was 160.4 sec and 85.94 sec respectively in Group A and Group B. The clinical duration was found to be 48.9 mins and 32.8 min respectively in group A and B. Total intubation score achieved at 60 secs was 6.36 and 8.12 seconds respectively for group A and group B. Conclusion: Rocuronium has a rapid onset of action with good intubating conditions, Cisatracurium has an intermediate duration of action, and both are potent and safe with excellent cardiovascular stability and without apparent histamine release.

References

No records found.


About this article

Cite this article

Licence:



Received Accepted Published
N/A N/A N/A
DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.4317.41

Keywords

Cisatracurium; Complications; Equipotent Doses; Rocuronium. 

Article Level Metrics

Last Updated

Saturday 28 February 2026, 23:27:06 (IST)

1393

Accesses

0
246
00

Citations


NA
NA
NA

Download citation


Article Keywords

Keyword Highlighting

Highlight selected keywords in the article text.


Timeline

Received N/A
Accepted N/A
Published N/A

licence




Access this article

Reprint Order Form
Buy this Article
Institutional Subscriptions

Share